欢迎来到 AntibodySystem中国区代理商/公司/官网
全国咨询热线： 18771997407
产品中心 植物学产品 分子生化产品 细胞生物学产品 免疫学产品
联系我们

地址：武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301

电话：18995651644

传真：18771997407

邮箱：sales@amyjet.com

新闻中心
Berry & Associates.png

艾美捷科技代理Berry & Associates全系列修饰核苷酸等


美国 Berry & Associates 公司成立于1989年，提供近200种亚磷酰胺和核苷酸合成用固相交联单体，以及数百种核苷、核苷酸、糖类、荧光标记物、淬灭剂和杂环化合物。

 

Founded in 1989 with roots in the nucleoside field, Berry & Associates soon moved into the chemistry of nucleic acids, resulting in a current portfolio of nearly 200 phosphoramidites and solid phase-linked monomers for oligonucleotide synthesis as well as hundreds of nucleosides, nucleotides, carbohydrates, spacers, fluorescent markers, quenchers, and heterocycles - all proudly made at our facility just outside of Ann Arbor, Michigan. Although our company is small, the credentials of our highly trained staff of chemists include over 400 publications and 80 patents in synthetic organic and medicinal chemistry.  High quality chemicals, timeliness, and personalized service are the hallmarks of Berry & Associates.


Berry & Associates的主要产品包括：

产品名称产品编号纯度规格
2',3'-DideoxyadenosinePR 3495≥95%25 mg; 100 mg
2'-3'-DideoxyguanosinePR 3505≥95%25 mg; 100 mg
2',3'-DideoxyinosinePR 3727≥97%100 mg; 1 g
3'-DeoxythymidinePY 7277≥95%50 mg; 100 mg
2',3'-DideoxyuridinePY 7278≥97%100 mg; 500 mg
2',3'-Didehydro-2',3'-dideoxyuridinePY 7279≥97%25 mg; 100 mg
2',3'-DideoxycytidinePY 7325≥95%50 mg; 100 mg
2-Aminoadenosine (2,6-Diaminopurine riboside)PR 3030≥97%2 g; 10 g
2-Amino-2'-deoxyadenosinePR 3060≥97%1 g; 5 g
2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-deoxyadenosinePR 3080≥95%100 mg; 1 g
2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosinePR 3090≥97%250 mg; 1 g
2-Amino-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosinePR 3110≥95%250 mg; 1 g
2-Amino-N2-isobutyryl-2'-deoxyadenosinePR 3130≥95%100 mg; 1 g
2-Amino-N2-O-methyladenosinePR 3150≥97%1 g; 10 g
2-(Dimethylaminomethylidene)amino-6-methoxylamino-9-(β-D-2-deoxyribofuranosyl)purinePR 3670≥95%100 mg; 1 g
2-Amino-9-(β-D-2'-deoxyribfuranosyl)purinePR 3070≥97%25 mg; 100 mg
2-Amino-9-(2-O-methyl-β-D-ribofuranosyl)purinePR 3160≥97%100 mg; 250 mg
2-Amino-9-(β-D-ribofuranosy)purine HemihydratePR 3180≥97%25 mg; 100 mg
2-(Dimethylaminomethylidene)amino-9-(β-D-2-deoxyribofuranosyl)purinePR 3680≥97%100 mg; 1 g
6-N-Acyl-6-N-methyl-2'-deoxyadenosinePR 3006≥95%25 mg; 100 mg
8-Amino-2'-deoxyadenosinePR 3115≥97%10 mg; 100 mg
N6-(6-Aminohexyl)-2'-deoxyadenosinePR 3120≥90%100 mg; 1 g
8-Azido-2'-deoxyadenosinePR 3125≥97%10 mg; 100 mg
N6-Benzoyl-8-benzyloxy-2'-deoxyadenosinePR 3230≥95%50 mg; 250 mg
N6-Benzoyl-5'-O-(dimethoxytrityl)-8-oxo-2'-deoxyadenosinePR 3260≥95%100 mg; 1 g
N6-Benzoyl-8-oxo-2'-deoxyadenosinePR 3270≥97%100 mg; 1 g
8-Benzyloxy-2'-deoxyadenosinePR 3280≥97%100 mg; 1 g
8-Bromo-2'-deoxyadenosinePR 3290≥90%2 g; 10 g
8-Bromo-N6-(dimethylaminomethylidene)-2'-deoxyadenosinePR 3320≥95%100 mg; 1 g
8-Bromo-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-2'-deoxyadenosinePR 3340≥97%0g (discontinued);  
2'-Deoxyadenosine MonohydratePR 3445≥97%25 g; 100 g
2',3'-DideoxyadenosinePR 3495≥95%25 mg; 100 mg
2-Fluoro-2'-deoxyadenosinePR 3496≥97%25 mg; 1 g
8-Oxo-2'-deoxyadenosinePR 3705≥95%25 mg; 250 mg
N6-Methyl-2'-deoxyadenosinePR 3740≥97%100 mg; 1 g
4-Chloro-1-(2-deoxy-β-D-ribofuranosyl)-7-methyl-1H-imidazo[4,5-c]pyridinePRA 10012≥95%10 mg; 50 mg
3-Deaza-3-methyl-2'-deoxyadenosinePRA 10013≥97%10 mg; 25 mg
5'-O-Dimethoxytrityl-N6-(N,N-dimethylaminomethylene)-8-aza-7-deaza-2'-deoxyadenosinePRA 10019≥97%500 mg; 1 g
7-(3-Nitrophenyl)-7-deaza-2'-deoxyadenosinePRA 10032≥95%10 mg; 50 mg
5-Iodo-2'-deoxytubercidinPRA 10036≥95%10 mg; 50 mg
8-Allyloxy-2'-deoxyguanosinePR 3010≥90%0Discontinued;  
8-Allyloxy-N2-(dimethylaminomethylidene)-2'-deoxyguanosinePR 3015≥90%1 g; 10 g
8-Allyloxy-N2-isobutyryl-2'-deoxyguanosinePR 3020≥90%1 g; 10 g
5'-Azido-5'-deoxyguanosinePR 3225≥90%5 mg; 10 mg
8-Benzyloxy-N2-isobutyryl-2'-deoxyguanosinePR 3285≥90%1 g; 10 g
8-Bromo-2'-deoxyguanosinePR 3300≥90%1 g; 5 g
8-Bromo-5'-O-(dimethyoxytrityl)-N2-(dimethyl-aminomethylidene)-2'-deoxyguanosinePR 3310≥97%500 mg; 1 g
8-Bromo-N2-(dimethylaminomethylidene)-2'-deoxyguanosinePR 3330≥90%250 mg; 1 g
5'-O-Dimethoxytrityl-N2-(dimethylaminomethylidene)-8-ethenyl-2'-deoxyguanosinePR 3335≥95%100 mg; 1 g
2'-Deoxyguanosine monohydratePR 3452≥97%10 g; 100 g
α-2'-DeoxyguanosinePR 3455≥97%10 mg; 100 mg
2'-DeoxyisoguanosinePR 3465≥97%10 mg; 100 mg
5'-O-(Dimethoxytrityl)-N2-ethyl-2'-deoxyguanosinePR 3600≥97%100 mg; 1 g
3',5'-Di-O-acetyl-2'-deoxyguanosinePR 3605≥97%500 mg; 1 g
5'-O-(Dimethoxytrityl)-8-Oxo-N2-isobutyryl-2'-deoxyguanosinePR 3610≥97%100 mg; 1 g
5'-O-(Dimethoxytrityl)-N2-methyl-2'-deoxy-guanosinePR 3630≥97%100 mg; 1 g
N2-Ethyl-2'-deoxyguanosinePR 3700≥95%25 mg; 100 mg
5'-O-Dimethoxytrityl-N2-(trifluoroacetamido)hexyl-2'-deoxyguanosinePR 3701≥95%25 mg; 100 mg
8-Oxo-2'-deoxyguanosinePR 3710≥97%25 mg; 250 mg
8-Oxo-N2-isobutyryl-2'-deoxyguanosinePR 3720≥90%100 mg; 1 g
N2-Isobutyl-2'-deoxyguanosinePR 3745≥97%10 mg; 100 mg
N1-Methyl-2'-deoxyguanosinePR 3748≥97%25 mg; 1 g
N2-Methyl-2'-deoxyguanosinePR 3750≥97%25 mg; 100 mg
O6-Methyl-2'-deoxyguanosinePR 3755≥90%5 mg; 25 mg
6-Thio-2'-deoxyguanosinePR 3845≥97%10 mg; 100 mg
7-Methyl-7-deaza-2'deoxyguanosinePRA 10042≥97%10 mg; 50 mg
2'-DeoxypseudoguanosinePRA 10103≥97%10 mg; 50 mg
2'-DeoxypseudoisoguanosinePRA 10104≥97%10 mg; 100 mg
8-Aza-7-deaza-2'-deoxyguanosinePRA 10170≥95%10 mg; 100 mg
6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-onePRA 10175≥95%10 mg; 100 mg
2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosinePR 3090≥97%250 mg; 1 g
2-Amino-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosinePR 3110≥95%250 mg; 1 g
2-Amino-N2-O-methyladenosinePR 3150≥97%1 g; 10 g
2',3'-Di-O-methyladenosinePR 3540≥97%100 mg; 1 g
5'-O-(Dimethoxytrityl)-2'-O-methylinosinePR 3640≥97%1 g;  
N6-Methyl-2'-O-MethyladenosinePR 3733≥97%50 mg; 100 mg
2'-O-MethyladenosinePR 3734≥97%1 g;  
2'-O-MethylguanosinePR 3760≥97%1 g; 10 g
2'-O-MethylinosinePR 3770≥97%500 mg; 1 g
N4-Acetyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidinePY 7010≥95%0 g DISCONTINUED;  
N4-Acetyl-5'-methyl-2'-O-methylcytidinePY 7020≥97%0 g DISCONTINUED;  
N4-Benzoyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidinePY 7100≥95%100 mg; 1 g
N4-Benzoyl-2'-O-methylcytidinePY 7110≥97%500 mg; 1 g
3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridinePY 7290≥95%500 mg; 1 g
3',5'-Di-O-acetyl-5-fluoro-2'-O-methyluridinePY 7300≥97%50 mg; 250 mg
3',5'-Di-O-benzoyl-5-fluoro-2'-O-methyluridinePY 7320≥97%500 mg; 1 g
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-iodo-2'-O-methylcytidinePY 7350≥97%0     DISCONTINUED;  
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidinePY 7360≥97%0     DISCONTINUED;  
N4-(Diisobutylaminomethylidene)-5-iodo-2'-O-methylcytidinePY 7370≥97%0     DISCONTINUED;  
5'-O-(Dimethoxytrityl)-5-fluoro-2'-O-methyluridinePY 7420≥95%100 mg; 500 mg
5'-O-(Dimethoxytrityl)-5-iodo-2'-O-methyluridinePY 7460≥97%50 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-methyl-2'-O-methyluridinePY 7470≥97%100 mg; 1 g
5'-O-(Dimethoxytrityl)-2'-O-methyluridinePY 7480≥97%500 mg; 1 g
5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridinePY 7500≥95%25 mg; 100 mg
5-Fluoro-2'-O-methyluridinePY 7570≥97%50 mg; 100 mg
5-Fluoro-2'-O-methyl-4-thiouridinePY 7575≥97%10 mg; 100 mg
5-Fluoro-2'-O-methyl-4-(methylithio)uridinePY 7577≥97%10 mg; 100 mg
5-Iodo-2'-O-methylcytidinePY 7620≥90%20 mg; 100 mg
5-Iodo-2'-O-methyluridinePY 7630≥97%100 mg; 1 g
2'-O-MethylcytidinePY 7636≥97%1 g; 5 g
5-Methyl-2'-O-methylcytidinePY 7640≥97%100 mg; 500 mg
5-Methyl-2'-O-methyluridinePY 7650≥97%100 mg; 1 g
5-(1-Propynyl)-2'-O-methylcytidinePY 7660≥95%10 mg; 50 mg
5-(1-Propynyl)-2'-O-methyluridinePY 7670≥97%10 mg; 25 mg
2'-O-MethyluridinePY 7690≥97%5 g;  
5'-O-Acetyl-3'-azido-N2-palmitoyl-2',3'-dideoxy-guanosinePR 3000≥97%25 mg; 250 mg
3'-Azido-N6-benzoyl-2',3'-dideoxyadenosinePR 3200≥90%50 mg; 250 mg
3'-Azido-2',3'-dideoxyadenosinePR 3210≥97%10 mg; 25 mg
3'-Azido-2',3'-dideoxyguanosinePR 3220≥97%10 mg; 25 mg
3'-Azido-3'-deoxythymidine (AZT)PY 7065≥97%500 mg; 1 g
3'-Azido-3'-deoxy-5'-O-methylthymidinePY 7075≥97%0 g DISCONTINUED;  
3'-Azido-2',3'-dideoxy-5-bromouridinePY 7286≥97%10 mg; 50 mg
N6-Benzoyl-3'-deoxyadenosinePR 3240≥97%100 mg; 1 g
N6-Benzoyl-5'-O-(dimethoxytrityl)-3'-deoxyadenosinePR 3250≥97%100 mg; 1 g
3'-DeoxyadenosinePR 3430≥97%10 mg; 100 mg
3'-DeoxyguanosinePR 3460≥97%10 mg; 100 mg
5'-O-(Dimethoxytrityl)-N2-(dimethylaminomethylidene)-3'-deoxyguanosinePR 3590≥97%100 mg; 1 g
N2-(Dimethylaminomethylidene)-3'-deoxyguanosinePR 3690≥97%20 mg; 100 mg
2'-O-Acetyl-5'-O-benzoyl-5-methyl-3'-deoxyuridinePY 7000≥97%500 mg; 1 g
N4-Benzoyl-3'-deoxycytidinePY 7080≥97%20 mg; 100 mg
3'-DeoxycytidinePY 7220≥97%20 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-methyl-3'-deoxyuridinePY 7240≥95%25 mg; 100 mg
5-Methyl-3'-deoxyuridinePY 7260≥95%20 mg; 50 mg
5'-O-(Dimethoxytrityl)-5,6-dihydro-2'-deoxyuridinePY 7230≥97%100 mg;  
5,6-Dihydro-2'-deoxyuridinePY 7330≥97%100 mg;  
(5S)-5,6-DihydrothymidinePY 7340≥97%20 mg; 100 mg
(5S)-5'-O-(Dimethoxytrityl)-5,6-dihydrothymidinePY 7390≥97%100 mg;  
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidinePY 7360≥97%0     DISCONTINUED;  
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-deoxycytidinePY 7400≥97%100 mg; 500 mg
5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-deoxyuridinePY 7490≥95%50 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridinePY 7500≥95%25 mg; 100 mg
5-(1-Propynyl)-2'-O-methylcytidinePY 7660≥95%10 mg; 50 mg
5-(1-Propynyl)-2'-O-methyluridinePY 7670≥97%10 mg; 25 mg
5-(1-Propynyl)-2'-deoxycytidinePY 7700≥90%5 mg; 10 mg
5-(1-Propynyl)-2'-deoxyuridinePY 7710≥97%100 mg; 1 g
2-Amino-6-chloro-9-(β-D-2-deoxyribofuranosyl)purinePR 3040≥97%1 g;  
2-Amino-6-chloro-9-(3,5-di-(p-toluoyl)-β-D-2-deoxyribofuranosyl)purinePR 3045≥95%1 g;  
2-Amino-6-chloro-9-(β-D-ribofuranosyl)purinePR 3050≥95%5 g; 25 g
6-Chloro-9-(β-D-2-deoxyribofuranosyl)purinePR 3370≥97%100 mg; 1 g
6-Chloro-9-(3,5-O-di-(p-toluoyl)-β-D-2-deoxyribofuranosyl)purinePR 3380≥90%100 mg; 1 g
6-Chloro-9-(5-O-dimethoxytrityl-β-D-2-deoxyribofuranosyl)purinePR 3390≥97%0 g;  
6-Chloro-9-(β-D-ribofuranosyl)purinePR 3400≥97%5 g; 10 g
AdenosinePR 3005≥97%100 g; 1 kg
8-MethyladenosinePR 3007≥95%25 mg; 100 mg
VidarabinePR 3008≥97%1 g; 5 g
2-Aminoadenosine (2,6-Diaminopurine riboside)PR 3030≥97%2 g; 10 g
N1-Methyladenosine hydroiodidePR 3032≥95%100 mg; 1 g
2-MethyladenosinePR 3035≥97%10 mg; 25 mg
5'-Chloro-5'-deoxyadenosinePR 3360≥97%100 mg; 1 g
N6-MethyladenosinePR 3732≥97%100 mg; 1 g
N6-Methyl-2'-O-MethyladenosinePR 3733≥97%50 mg; 100 mg
3-Deaza-3-methyl-2'-deoxyadenosinePRA 10013≥97%10 mg; 25 mg
7-Deazaadenosine (tubercidin)PRA 10035≥97%10 mg; 100 mg
5-Iodo-2'-deoxytubercidinPRA 10036≥95%10 mg; 50 mg
2-Amino-4-chloro-7-(β-D-2-deoxyribofuranosyl)pyrrolo[2,3-d]pyrimidinePRA 10000≥97%100 mg; 1 g
2-Amino-4-methoxy-7-(β-D-2-deoxyribofuranosyl)pyrrolo[2,3-d]pyrimidinePRA 10005≥97%500 mg; 1 g
4-Chloro-1-(β-D-2-deoxyribofuranosyl)imidazo[4,5-C]pyridinePRA 10006≥90%25 mg; 100 mg
8-AzaadenosinePRA 10007≥97%20 mg;  
8-Aza-7-deaza-2'-deoxyadenosine (4-Amino-1-(2-deoxyribofuranosyl)pyrazolo[3,4-d]-pyrimidine)PRA 10008≥95%10 mg; 100 mg
4-Chloro-1-(3,5-di-O-toluoyl-2-deoxy-β-D-ribofuranosyl)pyrazolo[3,4-d]pyrimidinePRA 10009≥95%100 mg; 1 g
N6-Benzoyl-7-deaza-2'-deoxyadenosinePRA 10010≥97%100 mg; 1 g
Allopurinol ribosidePRA 10011≥97%25 mg; 1 g
5'-O-Dimethoxytrityl-N6-(N,N-dimethylaminomethylene)-8-aza-7-deaza-2'-deoxyadenosinePRA 10019≥97%500 mg; 1 g
N6-Benzoyl-5'-O-(dimethoxytrityl)-7-deaza-2'-deoxyadenosinePRA 10020≥97%100 mg; 1 g
3-Deaza-2'-deoxyadenosinePRA 10025≥97%25 mg; 100 mg
7-Deaza-2'-deoxyadenosinePRA 10030≥97%100 mg; 1 g
7-Deazaadenosine (tubercidin)PRA 10035≥97%10 mg; 100 mg
5-Iodo-2'-deoxytubercidinPRA 10036≥95%10 mg; 50 mg
7-Deaza-2'-deoxyguanosinePRA 10040≥97%100 mg; 1 g
7-DeazaguanosinePRA 10045≥97%10 mg; 100 mg
7-Deaza-2'-deoxyxanthosinePRA 10050≥97%50 mg; 100 mg
5'-O-(Dimethoxytrityl)-7-deaza-2'-deoxyxanthosinePRA 10055≥97%100 mg; 1 g
1-(β-D-2-Deoxyribofuranosyl)-5-nitroindolePRA 10060≥97%100 mg; 1 g
1-(β-D-2-Deoxyribofuranosyl)-4-methylindolePRA 10070≥97%0 g;  
1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-4-methylindolePRA 10080≥97%0 g;  
1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-5-nitroindolePRA 10090≥97%100 mg; 1 g
5-IodotubercidinPRA 10095≥90%5 mg; 25 mg
5'-O-(Dimethoxytrityl)-N2-(dimethylaminomethylidene)-7-deaza-2'-deoxyguanosinePRA 10100≥97%100 mg; 1 g
N2-(Dimethylaminomethylidene)-7-deaza-2'-deoxyguanosinePRA 10110≥97%100 mg; 1 g
SangivamycinPRA 10140≥97%10 mg; 25 mg
ToyocamycinPRA 10150≥97%10 mg; 100 mg
TriciribinePRA 10160≥97%10 mg;  
Tricyclic Nucleoside PhosphatePRA 10162≥95%10 mg;  
8-Aza-7-deaza-2'-deoxyguanosinePRA 10170≥95%10 mg; 100 mg
6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-onePRA 10175≥95%10 mg; 100 mg
Formycin APYA 11001≥97%10 mg;  
Formycin BPYA 11002≥97%10 mg;  
dNaMFC 8110≥97%25 mg; 100 mg
9-Deaza-2'-deoxyguanosinePRA 10120≥97%10 mg; 100 mg
9-DeazaguanosinePRA 10130≥97%10 mg; 100 mg
2-Chloro-6-(β-D-2-deoxyribofuranosyl)-3,5-diaminopyrazinePYA 11000≥97%10 mg; 25 mg
Formycin APYA 11001≥97%10 mg;  
Formycin BPYA 11002≥97%10 mg;  
PyrazofurinPYA 11004≥97%10 mg;  
2'-DeoxypseudoisocytidinePYA 11005≥97%10 mg; 100 mg
2'-DeoxypseudouridinePYA 11010Purity: ≥97%25 mg; 
5'-O-(Dimethoxytrityl)-N-(dimethylamino)
methylidene-2'-deoxypseudoisocytidine		PYA 11035Purity: ≥97%50 mg; 100 mg
1,3-Dimethyl-2'-deoxypseudouridinePYA 11040≥97%10 mg; 100 mg
1,3-DimethylpseudouridinePYA 11050≥97%10 mg; 50 mg
N1-MethylpseudouridinePYA 11052≥95%10 mg; 50 mg
N3-MethylpseudouridinePYA 11054≥97%10 mg; 25 mg
ShowdomycinPYA 11056≥97%10 mg;  
Pseudoisocytidine hydrochloridePYA 11060≥97%10 mg; 100 mg
PseudothymidinePYA 11070≥97%10 mg; 100 mg
PseudouridinePYA 11080≥97%10 mg; 50 mg
3'-O-(t-Butyldimethylsilyl)-5'-oxo-2'-deoxy-8,5'-cycloadenosinePR 3350≥97%10 mg;  
(5'S)-8,5'-CycloadenosinePR 3410≥97%10 mg; 100 mg
(5'S)-2'-Deoxy-8,5'-cycloadenosinePR 3420≥97%10 mg;  
5'-Deoxy-8,5'-cycloadenosinePR 3440≥97%10 mg; 100 mg
2',5'-Dideoxy-8,5'-cycloadenosinePR 3500≥97%10 mg;  
2',3'-O-Isopropylidene-5'-oxo-8,5'-cycloadenosinePR 3730≥97%10 mg; 100 mg
5'-Oxo-8,5'-cycloadenosinePR 3800≥97%10 mg; 100 mg
5'-Oxo-2'-deoxy-8,5'-cycloadenosinePR 3810≥97%10 mg;  
N4-Acetyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidinePY 7010≥95%0 g DISCONTINUED;  
N4-Acetyl-5'-methyl-2'-O-methylcytidinePY 7020≥97%0 g DISCONTINUED;  
N4-Benzoyl-5-(furan-2-yl)-2'-deoxycytidinePY 7054≥97%25 mg; 100 mg
N4-Benzoyl-3'-deoxycytidinePY 7080≥97%20 mg; 100 mg
N4-Benzoyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidinePY 7100≥95%100 mg; 1 g
N4-Benzoyl-2'-O-methylcytidinePY 7110≥97%500 mg; 1 g
5-Bromo-2'-deoxycytidinePY 7115≥97%1 g; 10 g
CytidinePY 7215≥97%50 g; 500 g
2'-DeoxycytidinePY 7216≥97%10 g; 50 g
2'-Deoxycytidine HydrochloridePY 7217≥97%5 g; 50 g
5'-Azido-2',5'-dideoxycytidinePY 7219≥97%25 mg; 100 mg
3'-DeoxycytidinePY 7220≥97%20 mg; 100 mg
N4-Ethyl-2'-deoxycytidinePY 7245≥97%100 mg; 250 mg
5-Methyl-2'-deoxyisocytidinePY 7255≥95%500 mg; 1 g
6-(β-D-2-Deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido-[4,5-c][1,2]oxazin-7-onePY 7270≥97%20 mg; 50 mg
2',3'-DideoxycytidinePY 7325≥95%50 mg; 100 mg
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-iodo-2'-O-methylcytidinePY 7350≥97%0     DISCONTINUED;  
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidinePY 7360≥97%0     DISCONTINUED;  
N4-(Diisobutylaminomethylidene)-5-iodo-2'-O-methylcytidinePY 7370≥97%0     DISCONTINUED;  
6-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido-[4,5-c][1,2]oxazin-7-onePY 7380≥97%50 mg;  
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-deoxycytidinePY 7400≥97%100 mg; 500 mg
5-O-(Dimethoxytrityl)-N4-dimethylaminomethylidene-5-iodo-2'-deoxycytidinePY 7410≥97%100 mg;  
6-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido[4,5-c][1,2]oxazin-7-onePY 7540≥95%250 mg; 500 mg
Cytidin-5-yl-methanesulfonate sodium salt hydratePY 7586≥95%50 mg; 100 mg
5-[(2-Cyanoethoxy)methyl]-2'-deoxycytidinePY 7587≥97%10 mg; 50 mg
5-Hydroxymethyl-2'-deoxycytidinePY 7588≥97%50 mg; 100 mg
5-Formyl-2'-deoxycytidinePY 7589≥97%5 mg; 10 mg
5-Carboethoxy-2'-deoxycytidinePY 7592≥95%25 mg; 100 mg
2'-Deoxycytidine-5-carboxylic acid, sodium saltPY 7593≥95%25 mg; 100 mg
5-Hydroxy-2'-deoxycytidinePY 7595≥95%25 mg; 250 mg
5-HydroxymethylcytidinePY 7596≥97%50 mg; 100 mg
Cytidine-5-carboxylic acid, sodium saltPY 7598≥97%10 mg; 50 mg
5-FormylcytidinePY 7599≥97%5 mg; 10 mg
5-Iodo-2'-deoxycytidinePY 7607≥97%2 g; 10 g
5-IodocytidinePY 7609≥97%5 g;  
5-Iodo-2'-O-methylcytidinePY 7620≥90%20 mg; 100 mg
5-Methyl-2'-deoxycytidine HydrochloridePY 7635≥97%0.25 g; 1 g
2'-O-MethylcytidinePY 7636≥97%1 g; 5 g
5-MethylcytidinePY 7637≥97%1 g; 5 g
N4-MethylcytidinePY 7638≥97%25 mg; 100 mg
5-Methyl-2'-O-methylcytidinePY 7640≥97%100 mg; 500 mg
6-MethylcytidinePY 7641≥97%10 mg; 25 mg
5-(1-Propynyl)-2'-O-methylcytidinePY 7660≥95%10 mg; 50 mg
5-(1-Propynyl)-2'-deoxycytidinePY 7700≥90%5 mg; 10 mg
2-ThiocytidinePY 7721≥97%10 mg; 100 mg
2-Thio-2'-deoxycytidinePY 7723≥95%10 mg; 100 mg
3'-Deoxy-3',4'-didehydrocytidinePY 7790≥95%10 mg; 25 mg
Pyrrolo-dCPYA 11090≥95%10 mg; 100 mg
6-Methyl-3-(β-D-2-ribofuranosyl)pyrrolo[2,3-d]pyrimidin-2-onePYA 11092≥97%10 mg; 100 mg
3-(5'-O-Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-6-methylpyrrolo[2,3-d]pyrimidin-2-onePYA 11095≥95%100 mg; 1 g
3-(2'-Deoxy-β-D-2-ribofuranosyl)pyrido[2,3-d]pyrimidine-2,7(8H)-dionePYA 11100≥95%10 mg; 100 mg
3,N4-Etheno-2'-deoxycytidinePYA 11130≥97%100 mg; 500 mg
N6-Benzoyl-8-oxo-2'-deoxyadenosinePR 3270≥97%100 mg; 1 g
(5'S)-8,5'-CycloadenosinePR 3410≥97%10 mg; 100 mg
(5'S)-2'-Deoxy-8,5'-cycloadenosinePR 3420≥97%10 mg;  
5'-O-(Dimethoxytrityl)-8-Oxo-N2-isobutyryl-2'-deoxyguanosinePR 3610≥97%100 mg; 1 g
8-Oxo-2'-deoxyadenosinePR 3705≥95%25 mg; 250 mg
8-Oxo-2'-deoxyguanosinePR 3710≥97%25 mg; 250 mg
8-Oxo-N2-isobutyryl-2'-deoxyguanosinePR 3720≥90%100 mg; 1 g
8-HydroxyguanosinePR 3795≥97%10 mg; 100 mg
8-Aza-7-deaza-2'-deoxyguanosinePRA 10170≥95%10 mg; 100 mg
6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-onePRA 10175≥95%10 mg; 100 mg
5-Aza-2'-deoxycytidinePY 7105≥95%25 mg; 100 mg
5,6-Dihydro-5-aza-2'-deoxycytidinePY 7106≥97%25 mg; 100 mg
5,6-Dihydro-2'-deoxyuridinePY 7330≥97%100 mg;  
(5S)-5,6-DihydrothymidinePY 7340≥97%20 mg; 100 mg
5-Hydroxy-2'-deoxycytidinePY 7595≥95%25 mg; 250 mg
5-Hydroxy-2'-deoxyuridinePY 7597≥95%25 mg; 250 mg
5-(2-Hydroxyethyl)-2'-deoxyuridinePY 7600≥95%25 mg; 50 mg
5-Hydroxymethyl-2'-deoxyuridinePY 7605≥95%25 mg; 250 mg
6-MethylcytidinePY 7641≥97%10 mg; 25 mg
Nap-dUPY 7735≥97%10 mg; 25 mg
NPOM-Caged deoxythymidinePY 7795≥97%25 mg; 100 mg
3,N4-Etheno-2'-deoxycytidinePYA 11130≥97%100 mg; 500 mg
Pyrrolo-dCPYA 11090≥95%10 mg; 100 mg
6-Methyl-3-(β-D-2-ribofuranosyl)pyrrolo[2,3-d]pyrimidin-2-onePYA 11092≥97%10 mg; 100 mg
3-(5'-O-Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-6-methylpyrrolo[2,3-d]pyrimidin-2-onePYA 11095≥95%100 mg; 1 g
3-(2'-Deoxy-β-D-2-ribofuranosyl)pyrido[2,3-d]pyrimidine-2,7(8H)-dionePYA 11100≥95%10 mg; 100 mg
8-18O-HydroxyguanosineIOPR 3795≥95%2 mg; 5 mg
2'-DeoxyisoguanosinePR 3465≥97%10 mg; 100 mg
5'-O-Dimethoxytrityl-N2-(trifluoroacetamido)hexyl-2'-deoxyguanosinePR 3701≥95%25 mg; 100 mg
N2-DimethylguanosinePR 3702≥97%10 mg; 100 mg
GuanosinePR 3703≥97%100 g; 500 g
IsoguanosinePR 3735≥97%10 mg; 50 mg
O6-MethylguanosinePR 3757≥97%25 mg; 100 mg
2'-O-MethylguanosinePR 3760≥97%1 g; 10 g
7-Methyl-6-thioguanosinePR 3790≥75%25 mg; 100 mg
8-BromoguanosinePR 3796≥97%0 g;  
8-BenzyloxyguanosinePR 3797≥95%100 mg; 1 g
7-Methyl-7-deaza-2'deoxyguanosinePRA 10042≥97%10 mg; 50 mg
7-DeazaguanosinePRA 10045≥97%10 mg; 100 mg
5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dionePRA 10047≥97%10 mg; 100 mg
2'-DeoxypseudoguanosinePRA 10103≥97%10 mg; 50 mg
2'-DeoxypseudoisoguanosinePRA 10104≥97%10 mg; 100 mg
1-(β-D-2-Deoxyribofuranosyl)-5-nitroindolePRA 10060≥97%100 mg; 1 g
1-(β-D-2-Deoxyribofuranosyl)-4-methylindolePRA 10070≥97%0 g;  
1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-4-methylindolePRA 10080≥97%0 g;  
1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-5-nitroindolePRA 10090≥97%100 mg; 1 g
2'-Deoxy-4-desmethylwyosinePR 3450≥95%100 mg; 500 mg
2'-DeoxyinosinePR 3463≥97%10 g; 100 g
5'-Azido-2',5'-dideoxyinosinePR 3464≥97%5 mg; 25 mg
3',5'-Di-O-acetyl-2'-deoxyinosinePR 3480≥97%1 g;  
3',5'-Di-O-acetyl-O6-phenyl-2'-deoxyinosinePR 3490≥90%1 g;  
5'-O-(Dimethoxytrityl)-2'-O-methylinosinePR 3640≥97%1 g;  
5'-O-(Dimethoxytrityl)-O6-phenyl-2'-deoxyinosinePR 3660≥97%100 mg; 1 g
InosinePR 3725≥97%100 g; 500 g
2',3'-DideoxyinosinePR 3727≥97%100 mg; 1 g
2'-O-MethylinosinePR 3770≥97%500 mg; 1 g
7-MethylinosinePR 3780≥95%100 mg; 250 mg
O6-Phenyl-2'-deoxyinosinePR 3840≥97%100 mg; 1 g
2-Fluoro-6-O-(2-(4-nitrophenyl)ethyl)-2'-deoxyinosinePR 3842≥97%25 mg;  
5'-O-Dimethoxytrityl-2-fluoro-6-O-(2-(4-nitrophenyl)ethyl)-2'-deoxyinosinePR 3843≥90%25 mg; 100 mg
2'-DeoxyisoguanosinePR 3465≥97%10 mg; 100 mg
N6-(Diisobutylaminomethylidene)-2'-deoxyisoguanosinePR 3510≥90%100 mg; 1 g
N6-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-O2-(diphenylcarbamoyl)-2'-deoxyisoguanosinePR 3520≥95%100 mg; 1 g
N6-(Diisobutylaminomethylidene)-O2-(diphenylcarbamoyl)-2'-deoxyisoguanosinePR 3530≥90%100 mg; 1 g
IsoguanosinePR 3735≥97%10 mg; 50 mg
d5SICSFC 8120≥97%25 mg; 100 mg
AICA Riboside (AICAR)MN 20001≥97%0 g (DISCONTINUED);  
2',3'-Di-O-methyladenosinePR 3540≥97%100 mg; 1 g
2,6-Bis-O-[2-(4-nitrophenyl)ethyl]-2'-deoxyxanthosinePR 3692≥95%10 mg; 100 mg
5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dionePRA 10047≥97%10 mg; 100 mg
8-Aza-7-deaza-2'-deoxyguanosinePRA 10170≥95%10 mg; 100 mg
6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-onePRA 10175≥95%10 mg; 100 mg
3'-Deoxy-3',4'-didehydrocytidinePY 7790≥95%10 mg; 25 mg
NPOM-Caged deoxythymidinePY 7795≥97%25 mg; 100 mg
tC NucleosidePYA 11110≥97%50 mg; 100 mg
tCnitro NucleosidePYA 11115≥95%5 mg; 25 mg
2'-DeoxynebularinePR 3470

Purity: ≥97%		100 mg; 1 g
7-MethylinosinePR 3780≥95%100 mg; 250 mg
7-Methyl-6-thioguanosinePR 3790≥75%25 mg; 100 mg
1-(β-D-2-Deoxyribofuranosyl)-3-nitropyrrolePYA 11020≥97%50 mg;  
1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-3-nitropyrrolePYA 11030≥95%100 mg;  
ShowdomycinPYA 11056≥97%10 mg; 
Formycin APYA 11001≥97%10 mg; 
Formycin BPYA 11002≥97%10 mg; 
PseudouridinePYA 11080≥97%10 mg; 
PyrazofurinPYA 11004≥97%10 mg; 
ToyocamycinPRA 10150≥97%10 mg; 
7-Deazaadenosine (tubercidin)PRA 10035≥97%10 mg; 
Allopurinol ribosidePRA 10011≥97%25 mg; 
5-IodotubercidinPRA 10095≥90%5 mg; 
TriciribinePRA 10160≥97%10 mg; 
Tricyclic Nucleoside PhosphatePRA 10162≥95%10 mg; 
5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dionePRA 10047≥97%10 mg; 
5'-Amino-5'-deoxythymidinePY 7030≥97%25 mg; 50 mg
O2,5'-AnhydrothymidinePY 7060≥95%500 mg; 1 g
3'-Azido-3'-deoxythymidine (AZT)PY 7065≥97%500 mg; 1 g
5'-Azido-5'-deoxythymidinePY 7070≥97%25 mg; 100 mg
3'-Azido-3'-deoxy-5'-O-methylthymidinePY 7075≥97%0 g DISCONTINUED;  
3'-O-(t-Butyldimethylsilyl)-5'-deoxy-5'-(1,3-diphenyl-2-imidazolidinyl)thymidinePY 7120≥97%1 g;  
3'-O-(t-Butyldimethylsilyl)thymidinePY 7130≥95%500 mg; 1 g
5'-O-(t-Butyldimethylsilyl)thymidinePY 7140≥97%5 g; 10 g
3',5'-bis-O-(t-Butyldimethylsilyl)thymidinePY 7150≥97%1 g; 5 g
3',5'-bis-O-(t-Butyldimethylsilyl)-O4-(2,4,6-triisopropylphenylsulfonyl)thymidinePY 7160≥95%100 mg; 500 mg
S4-(2-Cyanoethyl)-5'-O-(dimethoxytrityl)-4-thiothymidinePY 7200≥95%10 mg; 100 mg
S4-(2-Cyanoethyl)-4-thiothymidinePY 7210≥95%10 mg; 100 mg
5'-Deoxy-5'-(1,3-diphenyl-2-imidazolidinyl)thymidinePY 7250≥97%1 g;  
3'-DeoxythymidinePY 7277≥95%50 mg; 100 mg
1-(3,5-Di-O-acetyl-β-D-deoxyribofuranosyl)-4-(1,2,4-triazol-1-yl)-5-methylpyrmidin-2-onePY 7315≥90%1 g; 10 g
2',3'-Didehydro-3'-deoxythymidinePY 7328≥95%10 mg; 100 mg
(5S)-5,6-DihydrothymidinePY 7340≥97%20 mg; 100 mg
(5S,6R)-5',6'-Cyclo-5'-deoxy-5,6-dihydrothymidinePY 7345≥95%10 mg; 25 mg
(5S)-5'-O-(Dimethoxytrityl)-5,6-dihydrothymidinePY 7390≥97%100 mg;  
5'-O-(Dimethoxytrityl)-N3/O4-(toluoyl)-2-thiothymidinePY 7510≥97%50 mg; 100 mg
2-O-EthylthymidinePY 7561≥97%500 mg; 1 g
5'-Iodo-5'-deoxythymidinePY 7610≥97%250 mg; 1 g
5'-O-MethylthymidinePY 7680≥95%50 mg; 100 mg
2-ThiothymidinePY 7725≥95%20 mg; 100 mg
ThymidinePY 7727≥97%25 g; 250 g
5'-O-(p-Toluenesulfonyl)thymidinePY 7740≥97%5 g;  
3-(2-Cyanoethyl)thymidinePY 7742≥95%10 mg; 25 mg
5'-Trifluoroacetamido-5'-deoxythymidinePY 7750≥97%50 mg;  
NPOM-Caged deoxythymidinePY 7795≥97%25 mg; 100 mg
6-Methyl-3-(β-D-2-deoxyribofuranosyl)furano-[2,3-d]pyrimidin-2-onePYA 11055≥97%5 mg; 25 mg
6-AzathymidinePYA 11058≥95%25 mg; 100 mg
NPOM-Caged-dT CEPBA 0317≥95%100 µmol; 0.25 g
5-[N-(2-Aminoethyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridinePY 7040≥97%100 mg; 1 g
5-[N-(6-Aminohexyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridinePY 7050≥90%100 mg; 1 g
3'-Azido-3'-deoxy-5'-O-methylthymidinePY 7075≥97%0 g DISCONTINUED;  
(E)-5-(2-Carbomethoxyvinyl)-2'-deoxyuridinePY 7170≥97%1 g;  
(E)-5-(2-Carboxyvinyl)-2'-deoxyuridinePY 7180≥97%500 mg; 1 g
(E)-5-(2-Carboxyvinyl)-2'-deoxyuridine N-Hydroxysuccinimide EsterPY 7190≥97%100 mg; 1 g
(5S,6R)-5',6'-Cyclo-5'-deoxy-5,6-dihydrothymidinePY 7345≥95%10 mg; 25 mg
5'-O-(Dimethoxytrityl)-5-[N-(2-(trifluoroacetamido)ethyl)-3-(E)acrylamido]-2'-deoxyuridinePY 7520≥97%100 mg; 1 g
5'-O-(Dimethoxytrityl)-5-[N-(6-(trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridinePY 7530≥97%100 mg; 1 g
1-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-5-(2-(phthalimidooxy)ethyl)-4-(1,2,4-triazol-1-yl)-lH-pyrimidin-2-onePY 7550≥95%100 mg; 1 g
3',5'-Di-O-(p-toluoyl)-5-(2-hydroxyethyl)-2'-deoxyuridinePY 7560≥95%500 mg; 1 g
5-(2-Hydroxyethyl)-2'-deoxyuridinePY 7600≥95%25 mg; 50 mg
3-(2-Cyanoethyl)thymidinePY 7742≥95%10 mg; 25 mg
5-[3-(Trifluoroacetamido)-E-1-propenyl]-2’-deoxyuridinePY 7754≥95%100 mg; 1 g
5-[N(2-(Trifluoroacetamido)ethyl)-3-(E)-acrylamido]-2'-deoxyuridinePY 7760≥90%100 mg; 1 g
5-[N(6-(Trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridinePY 7770≥95%100 mg; 1 g
NPOM-Caged deoxythymidinePY 7795≥97%25 mg; 100 mg
6-Methyl-3-(β-D-2-deoxyribofuranosyl)furano-[2,3-d]pyrimidin-2-onePYA 11055≥97%5 mg; 25 mg
5-Ethynyl uridine CEPBA 0353≥90%100 µmol; 0.25 g
2'-O-Acetyl-5'-O-benzoyl-5-methyl-3'-deoxyuridinePY 7000≥97%500 mg; 1 g
5-[N-(2-Aminoethyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridinePY 7040≥97%100 mg; 1 g
5-[N-(6-Aminohexyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridinePY 7050≥90%100 mg; 1 g
5-(Furan-2-yl)-2'-deoxyuridinePY 7053≥97%25 mg; 100 mg
1-(β-D-2-Deoxyribofuranosyl)-4-(1,2,4-triazol-1-yl)pyrimidin-2-onePY 7055≥97%20 mg; 100 mg
5-Bromo-2'-deoxyuridinePY 7117≥97%10 g; 25 g
5-BromouridinePY 7118≥95%5 g;  
(E)-5-(2-Carbomethoxyvinyl)-2'-deoxyuridinePY 7170≥97%1 g;  
(E)-5-(2-Carbomethoxyvinyl)uridinePY 7172≥97%25 mg; 250 mg
(E)-5-(2-Carboxyvinyl)-2'-deoxyuridinePY 7180≥97%500 mg; 1 g
(E)-5-(2-Carboxyvinyl)uridinePY 7185≥97%1 g;  
(E)-5-(2-Carboxyvinyl)-2'-deoxyuridine N-Hydroxysuccinimide EsterPY 7190≥97%100 mg; 1 g
S4-(2-Cyanoethyl)-4-thio-2'-deoxyuridinePY 7212≥95%10 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-methyl-3'-deoxyuridinePY 7240≥95%25 mg; 100 mg
5-Methyl-3'-deoxyuridinePY 7260≥95%20 mg; 50 mg
2'-DeoxyuridinePY 7275≥97%25 g; 100 g
3',5'-Di-O-acetyl-5-fluoro-2'-deoxyuridinePY 7280≥95%100 mg; 500 mg
3'-Azido-2',3'-dideoxy-5-bromouridinePY 7286≥97%10 mg; 50 mg
3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridinePY 7290≥95%500 mg; 1 g
3',5'-Di-O-acetyl-5-fluoro-2'-O-methyluridinePY 7300≥97%50 mg; 250 mg
3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-deoxyuridinePY 7310≥97%20 mg; 50 mg
3',5'-Di-O-benzoyl-5-fluoro-2'-O-methyluridinePY 7320≥97%500 mg; 1 g
5'-O-(Dimethoxytrityl)-5-fluoro-2'-O-methyluridinePY 7420≥95%100 mg; 500 mg
5'-O-(Dimethoxytrityl)-5-iodo-2'-deoxyuridinePY 7450≥97%500 mg; 1 g
5'-O-(Dimethoxytrityl)-5-iodo-2'-O-methyluridinePY 7460≥97%50 mg; 100 mg
5-Methoxymethyl-2'-deoxyuridinePY 7465≥95%10 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-methyl-2'-O-methyluridinePY 7470≥97%100 mg; 1 g
5'-O-(Dimethoxytrityl)-2'-O-methyluridinePY 7480≥97%500 mg; 1 g
5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-deoxyuridinePY 7490≥95%50 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridinePY 7500≥95%25 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-[N-(2-(trifluoroacetamido)ethyl)-3-(E)acrylamido]-2'-deoxyuridinePY 7520≥97%100 mg; 1 g
5'-O-(Dimethoxytrityl)-5-[N-(6-(trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridinePY 7530≥97%100 mg; 1 g
1-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-5-(2-(phthalimidooxy)ethyl)-4-(1,2,4-triazol-1-yl)-lH-pyrimidin-2-onePY 7550≥95%100 mg; 1 g
3',5'-Di-O-(p-toluoyl)-5-(2-hydroxyethyl)-2'-deoxyuridinePY 7560≥95%500 mg; 1 g
5-Ethynyl-2'-deoxyuridinePY 7562≥97%25 mg; 100 mg
5-Ethynyl uridinePY 7563≥97%10 mg; 100 mg
5-Fluoro-2'-deoxyuridinePY 7565≥97%100 mg; 1 g
5-Fluoro-2'-O-methyluridinePY 7570≥97%50 mg; 100 mg
5-Fluoro-O4-(2,4,6-trimethylphenyl)-2'-deoxyuridinePY 7580≥97%25 mg; 100 mg
5-Fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridinePY 7590≥95%25 mg; 100 mg
5-Hydroxy-2'-deoxyuridinePY 7597≥95%25 mg; 250 mg
5-(2-Hydroxyethyl)-2'-deoxyuridinePY 7600≥95%25 mg; 50 mg
5-Acetoxymethyl-2'-deoxyuridinePY 7604≥97%25 mg; 100 mg
5-Hydroxymethyl-2'-deoxyuridinePY 7605≥95%25 mg; 250 mg
2'-Fluoro-5'-iodo deoxyuridinePY 7612≥95%100 mg;  
5-Iodo-2'-deoxyuridinePY 7615≥97%10 g; 25 g
5-Iodo-2'-O-methyluridinePY 7630≥97%100 mg; 1 g
5-IodouridinePY 7632≥95%5 g; 25 g
5-Methyl-2'-O-methyluridinePY 7650≥97%100 mg; 1 g
5-(1-Propynyl)-2'-O-methyluridinePY 7670≥97%10 mg; 25 mg
2'-O-MethyluridinePY 7690≥97%5 g;  
3-MethyluridinePY 7694≥97%25 mg; 100 mg
5-MethyluridinePY 7695≥97%200 mg; 1 g
5-(1-Propynyl)-2'-deoxyuridinePY 7710≥97%100 mg; 1 g
5-(Propargyloxy)-2'-deoxyuridinePY 7712≥95%10 mg; 100 mg
ZebularinePY 7715≥97%10 mg; 25 mg
3',5'-O-(1,1,3,3-Tetraisopropyl-1,3-disiloxanediyl)-2'-deoxyuridinePY 7720≥90%500 mg; 1 g
2-ThiouridinePY 7724≥97%25 mg; 100 mg
5'-O-(p-Toluenesulfonyl)-2'-deoxyuridinePY 7730≥97%1 g; 5 g
5-[3-(Trifluoroacetamido)-E-1-propenyl]-2’-deoxyuridinePY 7754≥95%100 mg; 1 g
5-[3-(Trifluoroacetamido)-1-(E)-propenyl]uridinePY 7758≥97%100 mg; 1 g
5-[N(2-(Trifluoroacetamido)ethyl)-3-(E)-acrylamido]-2'-deoxyuridinePY 7760≥90%100 mg; 1 g
5-[N(6-(Trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridinePY 7770≥95%100 mg; 1 g
5-[N-(6-(Trifluoracetamido)hexyl)-(E)-acrylamido]uridinePY 7775≥97%100 mg; 1 g
UridinePY 7780≥97%100 g; 500 g
2'3'-O-Isopropylidene uridinePY 7781≥97%5 g; 25 g
5-Hydroxymethyl uridinePY 7782≥97%50 mg; 100 mg
5-MethoxyuridinePY 7783≥97%10 mg; 50 mg
6-Aza-2'-deoxyuridinePYA 11057≥95%50 mg; 100 mg

" data-original="http://antibody.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Berry & Associates全系列修饰核苷酸"> 艾美捷科技代理Berry & Associates全系列修饰核苷酸
...
阅读详情
exocell.jpgexocell.jpg

艾美捷科技代理Exocell品牌。

Exocell公司是一家专注于糖尿病及其并发症研究相关的产品与服务的生物制品公司。Exocell公司由Margo Cohen于1988年创立，致力于开发与糖尿病及其并发症相关的诊断产品。随着公司的不断发展，Exocell迅速成为该领域的重要供应商，拥有15项专利和2000多项研究引用。目前，Exocell产品已成为Ethos Biosciences（Ott Scientific的一部分）的一部分，继续为全球的学术、生物技术和制药研究团队提供服务。


Exocell产品与服务包括：

（1）临床诊断产品：

Albuwell：用于检测微白蛋白尿，是早期糖尿病性肾功能紊乱的明确标志物。

Creatinine：用于检测尿中的肌酐。

Glycaben：用于监测糖化白蛋白（中期的控糖指标）。

Glycacor：用于检测糖化LDL（短期控糖指标及心血管疾病风险指标）。

Hemoglobin A1c参照标准：长期控糖指标。


（2）临床研发类检测试剂与试剂盒：

Apo B Test：用于检测人血浆中的apolipoprotein B。

Collagen IV H：用于检测样本中的IV型胶原。

hFibronectin ELISA试剂盒：用于检测人血浆中的fibronectin。

Nephrin ELISA试剂盒：用于检测尿液中的nephrin等。


（3）实验室研究相关产品：

Albuwell M：用于检测小鼠样本中的微白蛋白尿。

Nephrat II：用于检测大鼠样本中的微白蛋白尿。

Glyco-Albumin R：用于检测大鼠血清中的糖化白蛋白等。


（4）糖尿病及其并发症研究相关的试剂及标准参照品：

A717：抗糖化白蛋白单克隆抗体。

E85：抗糖化血红素的单克隆抗体。

ES12：抗糖化LDL的单克隆抗体等。



<< " data-original="http://antibody.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Exocell品牌"> 艾美捷科技代理Exocell品牌
...
阅读详情
logo.png

<

艾美捷科技代理Bold Biotechnology（BBT）品牌全系列产品

Bold Biotechnology Co., Ltd (简称BBT)是一家综合性健康产业集团，拥有卓越的生命健康技术。BBT致力于研发全球最前沿的领先技术，涵盖以下领域：癌症预防、免疫细胞治疗（BAK、NK、DC免疫疗法）、外泌体研发、血清无免疫细胞用干细胞培养基、超早期癌症筛查、发酵马乳外泌体研发与生产，高浓度维他命C制备等十余项核心生物技术。BBT公司的主要包括细胞培养基相关产品以及免疫化学检测类相关产品。


BBT页面.png


▍BBT公司产品线

● αβ-T・γδ-T细胞培养基及配套产品

EALI515-T 无血清培养基：专用于人类及小鼠外周血淋巴细胞的培养。该培养基支持多种淋巴细胞的增殖与活化（包括αβ-T细胞、γδ-T细胞、CTL细胞、NKT细胞及NK细胞），适用于癌症免疫疗法。


ProductDescriptionCodePackageStore at
EALITM515-T (Without IL-2)Originally modified medium based on Iscove’s modified Dulbecco’s Medium (IMDM).
Basal medium for low-serum or serum-free culture of human and mouse Lymphoblast cells.
pH: 7.1-7.6
Osmolarity: 280-300 mOsm/Kg H2O
Membrane filtered, Endotoxin tested, Cell culture teste		15021,000 mL2～10℃


● NK细胞培养基

EALI515-NK 无血清培养基：专用于人类自然杀伤细胞（NK细胞）培养。本培养基支持NK细胞的活化与增殖，适用于癌症免疫疗法。

<
ProductDescriptionCodePackageStore at
EALITM515-NK (Without IL-2)Basal medium for low-serum or serum-free culture of human and mouse Lymphoblast & NK cells.
pH: 7.1-7.6
Osmolarity: 280-300 mOsm/Kg H2O
Membrane filtered, Endotoxin tested, Cell culture tested.		16021,000 mL2～10℃
EALITM515-NK (IL-2 700 IU/mL)Recommend for expansion culture of NK cells.
Containing 700 IU/mL of IL-2.
pH: 7.1-7.6
Osmolarity: 280-300 mOsm/Kg H2O
Membrane filtered, Endotoxin tested, Cell culture tested.		16221,000 mL2～10℃
EALITM515-NK (IL-2 1,000 IU/mL)Recommend for early stage culture of NK cells.
Containing 1,000 IU/mL of IL-2.
pH: 7.1-7.6
Osmolarity: 280-300 mOsm/Kg H2O
Membrane filtered, Endotoxin tested, Cell culture tested		16321,000 mL2～10℃


● 间充质干细胞（MSCs）无血清/无异源培养基及配套产品

αMSCM 培养基：基于改良型αMEM基础培养基优化开发，支持牙髓、脐带、骨髓及脂肪组织来源间充质干细胞（MSCs）的无异源/低血清培养。

<
ProductDescriptionCodePackageStore at
Basal medium (modified αMEM) αMSCM BasalA basal medium without L-Glutamine and Cell Growth Factors (GFs). (containing rh-Transferrin and rh-Insulin).
This product can be used for low serum culture of various MSCs. Add 2mM L-Glutamine, Cell growth Factors and 2% Fetus Bovine Serum (FBS) before use.
Recommend use of x100 3GF Supplement (code: 3151F) as additive.		1801500 mL2～10℃
Xeno-Free culture medium αMSCM+PLThis Product is a set of Xeno-Free medium and human Platelet Lysate (hPL:UltraGro*). No need additional growth supplements, serum and cell adhesion molecule.1811500 mL2～10℃
Cell Growth factor mixture x100 3GF SupplementA mixture of recombinant human FGF-2, PDGF-BB and TGF-β1. Contains recombinant human albumin as a stabilizer.This product is lyophilized.3151F5 mg4~8°C


● 蛋白质生产用化学成分确定培养基

EALI515-MAb 培养基：杂交瘤细胞培养与抗体生产专用培养基，本产品采用无动物源性蛋白配方（不含血清白蛋白），能支持多种杂交瘤细胞的高效增殖并维持抗体生产能力。培养基中仅含胰岛素与转铁蛋白两种蛋白组分，相比含血清或白蛋白的培养基，可显著简化培养上清中单克隆抗体的分离纯化流程。

<
ProductDescriptionCodePackageStore at
EALI 515-MAbNewly designed chemically defined medium of Hybridoma cell culture and production of Monoclonal Antibody. Containing hr-Insulin and hr-Transferrin.
Without Serum Albumin or other animal derived proteins.
pH: 7.3-7.7
Osmolarity: 280-300 mOsm/Kg H2O
Membrane filtered, Endotoxin tested, Cell culture tested.		14021,000 mL2～10℃


● 其他细胞培养相关产品


ProductDescriptionCodePackageStore at
Dulbecco’s Phosphate Buffered Saline, “PBS(-)”Dulbecco’s Phosphate–Buffered Saline
pH: 7.3-7.5
Osmolarity: 276-284 mOsm/Kg H2O
Membrane filtered
Endotoxin tested		2101500 mLRoom temp.
Anti CD3 MAb for CIK TactimabTMAffinity purified anti-CD3 monoclonal antibody without preservative.
Manufactured by animal protein free culture of mouse Hybridoma clone OKT3 cell.
Stimulate the growth of human T Lymphocyte in vitro.

Membrane filtered.
Endotoxin tested.
T cell culture tested.
This product is lyophilized.		3121F1 ㎎Freezing
Anti CD3 MAb for CIK TactimabTMAffinity purified anti-CD3 monoclonal antibody without preservative.
Manufactured by animal protein free culture of mouse Hybridoma clone OKT3 cell.
Stimulate the growth of human T Lymphocyte in vitro.

Membrane filtered.
Endotoxin tested.
T cell culture tested.
This product is lyophilized.		3122F10 ㎎Freezing


● 免疫化学检测试剂盒与试剂


ProductDescriptionCodePackage
CTX-ELISA 1BPlate Wash Buffer x20 conc, W-181111 x 50 mL
CTX-ELISA 1BSTD/Sample Diluent, D-181121 x 50 mL
CTX-ELISA 1BAnti-CTX1B-ALP Diluent, D-281131 x 50 mL
CTX-ELISA 1BALP Substrate Solution (pNPP), R-181141 x 50 mL
CTX-ELISA 1BELISA Assay Plate CTX1B　81152 x 96 well
CTX-ELISA 1BAnti-CTX1B-ALP：Freeze dry powder81161 tube
CTX-ELISA 1BCTX-1B STD 5 ng/mL81171 x 100 μL
CTX-ELISA 1BAdhesive plastic sheet--6 sheet
CTX-ELISA 1BOperation manual--1
Plate Wash Buffer x20 conc. W-1x20 concentrated Tris-buffer(pH 7.5) with tween 20, blocking reagent and preservative.
20 hold dilute with pure water before use.		811150 mL
STD/Sample Diluent D-1Specially developed buffer solution to dissolve hydrophobic Ciguatoxin molecule into the water.
pH 7.5.Ready to use.		811250 mL
Anti-CTX1B-ALP Diluent D-2Specially designed buffer solution(pH 7.5) for dilution of alkaline-phosphatase conjugated antibody, with Mg++, blocking material and detergent. Ready to use.811350 mL
ALP Substrate Solution (pNPP) R-1Alkaline-phosphatase substrate solution.
Alkaline solution of 0.01% disodium p-Nitrophenylphosphate (pNPP).
pH10,Useful for colorimetric assay of Alkaline-phosphatase. Ready to use.		811450 mL
ELISA Assay Plate CTX1BAnti-CTX1B antibody immobilized 96 well micro-plate.
Protected with blocking reagents to stabilize antibodies.
More than 8 months store is possible under dry conditions of 4 ℃ or less.		81151 plate



" data-original="http://antibody.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Bold Biotechnology（BBT）品牌全系列产品"> 艾美捷科技代理Bold Biotechnology（BBT）品牌全系列产品
...
阅读详情
logo-e1430252933504.png

<

艾美捷科技代理Nanosoftpolymers品牌全系列产品

Nanosoft Polymers（NSP）是一家专注于提供用于治疗、设备和诊断的即用型功能化聚合物和共聚物的企业，旨在弥合聚合物和药物递送之间的差距。NSP生产和销售一系列独特的功能性聚合物、共聚物和聚合物偶联物，其聚合物目录丰富多样，涵盖功能性PLGA - PEG、PLA - PEG、PCL - PEG、脂质PEG、聚（L - 赖氨酸）- PEG、聚（L - 谷氨酸）- PEG和聚乙二醇化试剂等。这些产品可应用于药物/基因递送、封装、细胞粘附和表面修饰等多个研究领域。除了销售现有产品，NSP还专门从事聚合物合成和功能化、纳米颗粒制造、表面改性以及具有广泛分子量范围的反应性低聚物和聚合物的定制合成，能够满足客户多样化的需求。


Nanosoftpolymers页面.png


▍Nanosoftpolymers产品线

● 多糖：是由长链单糖单元通过糖苷键连接而成的高分子碳水化合物，具有良好的生物相容性、无毒性和非免疫原性。

● 抗癌试剂与原料药：提供种类丰富的高品质抗癌试剂与原料药，用于药物研发。

● 脂质：NSP的功能性脂质用于制备脂质体或纳米颗粒，这些脂质体或纳米颗粒可通过脂质头部的官能团进一步进行生物偶联修饰。

● PEI-PEGs：NSP 的 PEI-PEG 聚合物包括 PEG 接枝的支链 PEI和 PEG 偶联的线性PEI，可用于体外和体内将寡核苷酸递送至细胞和组织。

● 聚氨基酸：可提高药物结合物的溶解度和稳定性、药物包封、药物靶向、绕过多药耐药因素、对免疫系统的刺激极小、低毒性以及生物可降解性。

● 脂质 - 聚乙二醇（Lipid-PEGs）：提供多样化的脂质及磷脂PEG衍生物，广泛应用于药物递送、脂质体 / 胶束形成、小分子和大分子药物制剂以及表面修饰等领域。

● Poly(amino acid)-PEGs：NSP 的 PEG-PAA 包括聚（L - 赖氨酸）-PEG、聚（L - 谷氨酸）-PEG、聚（L - 天冬氨酸）-PEG 及其功能化共聚物。

● 功能性聚乙二醇：提供多种高品质 PEG 试剂，用于聚乙二醇化、药物递送、生物偶联和表面修饰。NSP 的功能性聚乙二醇包括单线性聚乙二醇、同源双功能聚乙二醇、异源双功能聚乙二醇和多臂聚乙二醇。

● 单体：是一种可通过化学方式或超分子方式与其他分子结合，从而形成（超分子）聚合物的分子。

● 聚酯 - 聚乙二醇（Polyester-PEGs）：提供基于聚酯的功能性两亲性嵌段共聚物，如聚乳酸 - 聚乙二醇（PLA-PEG）、聚乳酸 - 羟基乙酸共聚物 - 聚乙二醇（PLGA-PEG）、聚己内酯 - 聚乙二醇（PCL-PEG），用于药物递送研究。

● 按官能团分类的聚合物：包括但不限于：胺基、Boc 或 Fmoc 保护的胺基、羧基、马来酰亚胺基、生物素、叠氮基、巯基、酰肼基、炔基、邻吡啶二硫基（OPSS）、活性琥珀酸酯基、乙烯基砜基（VS）、丙烯酸酯基、硝基苯基碳酸酯基（NPC）、二苯并环辛炔基（DBCO）、叶酸基等。

● 荧光聚合物：提供 “即开即用型” 荧光聚合物，研究人员可借助显微镜或 IVIS 成像技术对聚合物及纳米药物进行追踪。NSP的荧光染料包括罗丹明、荧光素、Cy3、Cy5.0、Cy5.5 及 Cy7 等。


▍Nanosoftpolymers部分产品列表


品名货号分子量规格
Hyaluronate Amine133905K, 10K, 50 K, 100 K, 1000 K, 1500 K100mg, 1g
Hyaluronate Thiol246565K, 10K, 50 K, 100 K, 1000 K, 1500 K100mg, 1g
Hyaluronic Acid Tetrabutylammonium1337850 K, 100 K, 1000 K, 1500 K100mg, 1g
Methacrylated Hyaluronic Acid (HA-MA)1320450 K, 100 K, 1000 K, 1500 K100mg, 1g
10-Hydroxycamptothecin11999364.35100mg, 500mg, 1g, 5g, 10g
7-Ethyl-10-hydroxycamptothecin12007392.420mg, 100mg, 500mg, 1g
Abarelix Acetate120141416.081mg, 5mg, 10mg, 25mg, 50mg, 100mg
Camptothecin11992348.35250mg, 500mg, 1g, 5g
Cisplatin12032300.05100mg, 200mg, 500mg, 1g
Cucurbitacin B11964558.7125mg, 10mg, 20mg, 50mg, 100mg
Cucurbitacin E12024556.6961mg, 5mg, 10mg, 25mg
Cyclosporine A120861202.61124100mg, 500mg, 1g, 5g, 10g
Doxorubicin hydrochloride11947579.9850mg, 100mg, 500mg, 1g
Irinotecan HCl11985677.1820mg, 50mg, 100mg, 500mg
Paclitaxel11955853.3309650mg, 100mg, 1g, 10g, bulk
Topotecan Hydrochloride11977457.9120mg, 50mg, 100mg, 500mg
β-Lapachone12048242.0942910mg, 25mg, 100mg
ALC-031528068766.290 50mg, 100mg, 200mg, 1g
DLin-KC2-DMA27581642.115mg, 10mg, 25mg, 50mg, 100mg, 200mg
DLin-MC3-DMA25325642.1150mg, 100mg, 1g, 5g
DODAP (18:1)26495648.05100mg, 500mg, 1g
DODMA27967620.10450mg, 100mg, 1g
DOTAP (18:1)25396698.555100mg, 500mg, 1g
DOTMA25335670.57550mg, 100mg, 1g
DSTAP (18:0)26129702.57100mg, 500mg, 1g
SM-10227852709.6650mg, 100mg, 200mg, 1g
ALC-031528068766.290 50mg, 100mg, 200mg, 1g
DLin-KC2-DMA27581642.115mg, 10mg, 25mg, 50mg, 100mg, 200mg
DSPC (18:0 PC)26737790.145500mg, 1g, 5g
DSPE13903748.07100mg, 200mg, 500mg, 1g
DSPE-Maleimide/DSPE-MAL10791898.1950mg, 100mg, 500mg
DSTAP (18:0)26129702.57100mg, 500mg, 1g
SM-10228527709.6650mg, 100mg, 200mg, 1g


" data-original="http://antibody.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Nanosoftpolymers品牌全系列产品"> 艾美捷科技代理Nanosoftpolymers品牌全系列产品
...
阅读详情


艾美捷科技代理GLYCON Biochemicals GmbH全系列产品。

主要产品包括：（1）非离子去污剂；（2）离子去污剂；（3）糖磷酸盐；（4）碳水化合物等。

<
产品名称货号化学式分子量CAS#
2,5-Anhydro-6-azido-6-deoxy-1,3-O-isopropylidene-D-glucitolS20031C9H15N3O4229,23N/A
4-Azido-4-deoxy-1,6:2,3-dianhydro-β-D-mannopyranoseS97085C7H9N3O2167,17N/A
Methyl-3,6-anhydro-7-azido-2,7-dideoxy-4,5-O-isopropylidene-D-alloheptonateS10191C11H17H3O5271,27N/A
1,4-Anhydro-3-azido-2-O-benzoyl-3-deoxy-D-xylitolS10192C12H13N3O4263,25N/A
1,4-Anhydro-2-azido-3-O-benzoyl-2-deoxy-D-arabitolS10189C12H13N3O4263,25N/A
2-Azido-2-deoxy-1,4;3,6-dianhydro-D-glucitolS03293C6H9N3O3171,15N/A
6-Azido-6-deoxy-1,2,3,4-tetra-O-acetyl-α,β-D-galactopyranoseS05174C14H19N3O9373,32N/A
6-Azido-6-deoxy-1,2,3,4-tetra-O-acetyl-α,β-L-galactopyranoseS02174C14H19N3O9373,32N/A
DIBMA free acidD-20054N/AN/AN/A
DIBMA monosodium saltD-20055N/AN/AN/A
Glyco-DIBMAD-20056N/AN/AN/A
n-Octyl α-D-glucopyranoside (aOG) > 99% highly purifiedD97011C14H28O6 292,3829781-80-4
Methyl 6-O-(-n-heptylcarbamoyl)-α-D-glucopyranoside (HECAMEG)D20034C15H29NO7 335,4115457-83-5
n-Hexyl β-D-glucopyranoside > 99% highly purifiedD99014C12H24O6  264,459080-45-4
n-Heptyl β-D-glucopyranoside (HeptG) > 99% highly purifiedD07033C13H26O6 278,478617-12-6
n-Octyl β-D-glucopyranoside (OG) > 99% highly purifiedD97001C14H28O6 292,3829836-26-8
n-Octyl β-D-glucopyranoside (OG-C) > 99,5% for crystallographyD97001-CC14H28O6 292,3829836-26-8
n-Nonyl β-D-glucopyranoside (NG) > 99% highly purifiedD99011C15H30O6 306,4069984-73-2
n-Nonyl β-D-glucopyranoside (NG-C) > 99,5% for crystallographyD99011-CC15H30O6 306,4069984-73-2
n-Decyl β-D-glucopyranoside (DG) > 99% highly purifiedD99006C16H32O6 320,4358846-77-8
n-Undecyl β-D-glucopyranoside (UDG) > 99% highly purifiedD11023C17H34O6 334,470005-86-6
n-Dodecyl β-D-glucopyranoside (DDG) > 99% highly purifiedD99007C18H36O6 348,559122-55-3
4-trans-(4-trans-Propylcyclohexyl)-cyclohexyl α-maltoside > 99% (t-PCCαM)D99019-CC27H47O11547,67N/A
n-Dodecyl α-maltoside (αDDM) > 99% highly purifiedD99020C24H46O11510,63116183-64-3
n-Hexyl β-maltoside (HexM) > 99% highly purifiedD20018C18H34O11426,4870287-95-9
n-Heptyl β-maltoside (HeptM) > 99% highly purifiedD14001C19H36O11440,48N/A
n-Octyl β-maltoside (OM) > 99% highly purifiedD20020C20H38O11454,482494-08-4
n-Nonyl β-maltoside (NM) > 99% highly purifiedD20015C21H40O11468,41106402-05-5
n-Nonyl β-maltoside (NM-C) > 99,5% for crystallographyD20015-CC21H40O11468,41106402-05-5
n-Decyl β-maltoside (DM) > 99% highly purifiedD99003C22H42O11482,682494-09-5
n-Decyl β-maltoside (DM-C) > 99,5% for crystallographyD99003-CC22H42O11482,682494-09-5
n-Undecyl β-maltoside (UDM) > 99% highly purifiedD99012C23H44O11496,6253678-67-0
n-Undecyl β-maltoside (UDM-C) > 99,5% for crystallographyD99012-CC23H44O11496,6253678-67-0
n-Dodecyl β-maltoside (DDM-C) > 99,5% for crystallographyD97002-CC24H46O11510,63
69227-93-6
n-Tridecyl β-maltoside (TDM) > 99%D20016C25H48O11524,693911-12-7
n-Tridecyl β-maltoside (TDM-C) > 99,5% for crystallographyD20016-CC25H48O11524,6
93911-12-7
n-Tetradecyl β-maltoside (TeDM-C) > 99,5% for crystallographyD20028-CC26H50O11538,618449-82-6
n-Pentadecyl β-maltoside (PDM-C) > 99,5% for crystallographyD20040-CC27H52O11552,35N/A
n-Hexadecyl β-maltoside (HeDM) > 99,5%D20029-CC28H54O11566,72
98064-96-1
n-Dodecyl β-maltoside (DDM) > 99% highly purifiedD97002C24H46O11510,6369227-93-6
Isopropyl 1-thio-β-D-galactopyranoside (IPTG)S02122C9H18O5 238,30
367-93-1
n-Heptyl 1-thio-β-D-glucopyranoside (HTG) > 99% highly purifiedD99013C13H26O5S294,4
85618-20-8
n-Octyl 1-thio-β-D-glucopyranoside (OTG) > 99% highly purifiedD20014C14H28O5S308,44
85618-21-9
n-Nonyl 1-thio-β-D-glucopyranoside (NTG-C) > 99,5% highly purifiedD14038-CC15H30O5S322,4
98854-15-0
n-Decyl 1-thio-β-D-glucopyranoside (DTG) > 99% highly purifiedD20021C16H32O5S336,4
98854-16-1
n-Dodecyl 1-thio-β-maltoside (DDTM-C) > 99,5% highly purifiedD20022-CC24H46O10S526,6
148565-58-6
n-Heptyl 1-thio-β-D-glucopyranoside (HTG-C) > 99,5% highly purifiedD99013-CC13H26O5S294,4
85618-20-8
n-Octyl 1-thio-β-D-glucopyranoside (OTG-C) > 99,5% highly purifiedD20014-CC14H28O5S308,44
85618-21-9
MEGA-8 (N-Octanoyl-N-methylglucamin)D98004C15H31NO6321,4
85316-98-9
MEGA-9 (N-Nonanoyl-N-methylglucamin)D99005C16H33NO6335,4
85261-19-4
MEGA-10 (N-Decanoyl-N-methylglucamin)D99008C16H33NO6335,4
85261-19-4
1-O-(n-Octyl)-tetraethyleneglycol (C8E4)D20038C16H34O5306,44
19327-39-0
1-O-(n-Decyl)-hexaethyleneglycol  (C10E6)D20041C22H46O7422,60
5168-89-8
1-O-(n-Decyl)-nonaethyleneglycol  (C10E9)D20033C28H58O10554,75
26183-52-81
1-O-(n-Dodecyl)-tetraethyleneglycol (C12E4)D20035C20H42O5362,54
5274-68-0
1-O-(n-Dodecyl)-octaethyleneglycol (C12E8)D20039C28H58O9538,75
3055-98-9
1-O-(n-Dodecyl)-nonaethyleneglycol (C12E9)D20032C30H62O10582,81
3055-99-0
1-O-(n-Dodecyl)-decaethyleneglycol (C12E10)D20031C32H66O11626,86
6540-99-4
1-O-(n-Tridecyl)-octaethyleneglycol (C13E8)D20030C29H60O9552,78
9043-30-5
N,N-Dimethyl-n-dodecylamine-N-oxide (LDAO)D71111C14H31NO229,4
1643-20-5
Sucrose monolaurate (SUMOL)S98001C24H44NO12524,6
25339-99-5
Monoolein (1-O-Oleoyl-rac-glycerol)D20036C21H40O4356,5
111-03-5
3-[(3-Cholamidopropyl)-dimethylammonio]-1-propane sulfonateD99009C32H58N2O7S614,8975621-03-3
3-[(3-Cholamidopropyl)-dimethylammonio]-2-hydroxy-1-propane sulfonateD99010C32H58N2O8S 630,87
82473-24-3
n-Nonyl-phosphocholine (C9-PC)  Purity > 99%S10197C14H32NO4P 309,38
253678-64-7
n-Decyl-phosphocholine (C10-PC) Purity > 99%S10195C15H34NO4P 323,41
70504-28-8
n-Undecyl-phosphocholine (C11-PC) Purity > 99%S10196C16H36NO4P337,4
253678-65-8
n-Dodecyl-phosphocholine (C12-PC) Purity > 99%S10190C17H38NO4P351,46
29557-51-5
n-Tridecyl-phosphocholine (C13-PC) Purity > 99%S10198C18H40NO4P365,49
85775-42-4
n-Tetradecyl-phosphocholine (C14-PC) Purity > 99%S10194C19H42NO4P379,51
77733-28-9
n-Pentadecyl-phosphocholine (C15-PC) Purity > 99%S10199C20H44NO4P393,54
146801-07-2
n-Hexadecyl-phosphocholine (C16-PC) Purity > 99%S01241C21H46NO4P407,57
58066-85-6
α-D-Galactopyranose-phosphate  di-potassium salt dihydrateP0001C6H11K2O9P. 2H2O372,36
19046-60-7
α-D-Glucopyranose-phosphate  di-potassium salt dihydrateP0002C6H11K2O9P. 2H2O372,36
5996-14-5
α-D-Mannopyranose-phosphate di-potassium salt dihydrateP0003C6H11K2O9P. 2H2O372,3671888-67-0
N-Acetyl-D-galactosamine  (2-Acetamido-2-deoxy-D-galactose, GalNAc)S96001C8H15NO6221,21
1811-31-0
N-Acetyl-D-glucosamine  (2-Acetamido-2-deoxy-D-glucose, GlcNAc)S93002C8H15NO6221,21
7512-17-6
2-Acetamido-2-deoxy-β-D-glucopyranosylaminS98003C8H16N2O5220,21
18615-50-4
N-Acetyl-D-mannosamine x H2O  (2-Acetamido-2-deoxy-D-mannose monohydrate, D-ManAc x H2O)S94004C8H17NO7239,23
7772-94-3
1,3,4,6-tetra-O-acetyl-β-D-GlcNAc  (2-Acetamido-2-deoxy-1,3,4,6-tetra-O-acetyl-β-D-glucopyranose)S94005C16H23NO10389.36
7772-79-4
3,4,6-tri-O-acetyl-β-D-GlcNAc azide  (2-Acetamido-3,4,6-tri-O-acetyl-2-deoxy-β-D-glucopyranosyl azide)S96006C14H20N4O8372,34
6205-69-2
3,4,6-tri-O-acetyl-α-D-GlcNAc chlorid  (2-Acetamido-2-deoxy-3,4,6-tri-O-acetyl-2-deoxy-α-D-glucopyranosyl chlorid)S97007C14H20CINO8366,80
3068-34-6
1,3,4,6-tetra-O-acetyl-α-D-glucosamine x HCl
(2-Amino-2-deoxy-1,3,4,6-tetra-O-acetyl-α-D-glucopyranose HCl)		S00116C14H22CINO9383,79N/A
Allyl 2-acetamido-2-deoxy-α-D-glucopyranosideS96008C11H19NO6261,28
54400-75-8
Allyl 2-acetamido-2-deoxy-β-D-glucopyranosideS96009C11H19NO6261,28
54400-77-0
Allyl α-D-galactopyranosideS96010C9H16O6220,22
48149-72-0
Allyl α-D-glucopyranosideS98011C9H16O6220,22
7464-56-4
Allyl β-D-glucopyranosideS98012C9H16O6220,22
34384-797
Allyl α-D-mannopyranosideS11118C9H16O6220,22
41308-76-3
Allyl 2,3,4-tri-O-benzyl-α-D-glucopyranosideS98013C30H34O6490,60N/A
1-Amino-1-deoxy-β-D-galactose (β-D-Galactopyranosylamine)S99102C6H13NO5179,17
50444-86-5
1,6-Anhydro-β-D-galactopyranoseS93014C6H10O5162,14
644-76-8
1,6:3,4-Dianhydro-2-O-tosyl-β-D-galactopyranoseS97016C13H14O6s234,25
6167-32-4
D-ArabinoseS93017C5H10O5150,13
28697-53-2
Arbutin (4-Hydroxyphenyl b-D-glucopyranoside, synthetic)S96018C12H16O7272,25
497-76-7
2-Azido-2-deoxy-1,3,4,6-tetra-O-acetyl-α-D-galactopyranoseS96021C14H19N3O9373,32N/A
2-Azido-2-deoxy-1,3,4,6-tetra-O-acetyl-α,β-D-galactopyranoseS97022C14H19N3O9373,32N/A
2-Azido-2-deoxy-1,3,4,6-tetra-O-acetyl-β-D-glucopyranoseS96024C14H19N3O9373,32N/A
2-Azido-2-deoxy-1,2‘,3,3‘,4‘,6,6‘-hepta-O-acetyl-α,β-lactose
2-Azido-2-deoxy-4-O-(2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl)-1,3,6-tri-O-acetyl-α,β-D-glucopyranose		S96025C26H35N3O17661,58N/A
2-Azido-2-deoxy-1,3,4,6-tetra-O-acetyl-α-D-mannopyranoseS97026C14H19N3O9373,32N/A
Benzyl 4,6-O-benzylidene-α-D-GlcNAcS97027C22H25NO6399,45
13343-63-0
Benzyl α-D-GlcNAc (Benzyl 2-acetamido-2-deoxy-α-D-glucopyranoside)S97028C15H21NO6311,34
13343-62-9
Benzyl α-D-mannopyranosideS97029C13H18O6270,28
155548-45-5
CellobioseS96030C12H22O11342,30
528-50-7
6-Deoxy-1,2:3,4-di-O-isopropylidene-α-D-galactopyranoseS96032C12H20O5244,29
4026-27-1
3,4-Di-O-acetyl-L-rhamnal (3,4-Di-O-acetyl-6-deoxy-L-glucal)S94035C10H14O5214.22
34819-86-8
1,4:3,6-Dianhydro-D-mannitolS97037C6H10O4146,15
641-74-7
1,2,3,4-Di-O-isopropylidene-α-D-galactopyranoseS95038C12H20O6260.29
4064-06-6
1,2:5,6-Di-O-isopropylidene-α-D-glucofuranoseS00112C12H20O6260,29
582-52-5
1,2:5,6-Di-O-isopropylidene-D-mannitolS95039C12H22O6262,31
1707-77-3
2,3:5,6-Di-O-isopropylidene-α-D-mannofuranoseS93040C12H20O6260.29
14131-84-1
1,2:3,5-Di-O-isopropylidene-α-D-xylofuranoseS00110C11H18O5230,26
20881-04-3
D-Fucose (6-Deoxy-D-galactose)S96042C6H12O6164,16 [3615-37-0]3615-37-0
L-Fucose (6-Deoxy-L-galactose)S96043C6H12O6164,16
2438-80-4
D-Galactosamine x HClS95044C6H13NO5 x HCl215.64
1172-03-8
D-Glucosamine x HClS93045C6H13NO5 x HCl215.64
66-84-2
L-GlucoseS94046C6H12O6180.16
921-60-8
2,3,3’,4,6,6’-Hexa-O-acetyl-lactalS97036
N/AN/A
1,2-O-Isopropylidene-α-D-glucofuranoseS00113C9H16O6220,22
18549-40-1
Isopropyl-β-D-thiogalactoside  IPTG (lactose based)S02122-LC9H18O5S238,31
367-93-1
Isopropyl-β-D-thiogalactoside  IPTG (on plant based)S02122-PC9H18O5S238,31
367-93-1
3,4-O-Isopropylidene-D-mannitolS94048C9H18O6222,22
369-84-4
1,2-O-Isopropylidene-α-D-xylofuranoseS00111C8H14O5190,20
20031-21-4
D-LyxoseS96051C5H10O5150,13
1114-34-7
L-LyxoseS96052C5H10O5150,13
1949-78-6
Maltose monohydrateS98053C12H22O11H2O360,32
6363-53-7
β-Maltose octaacetateS98054C28H38O19678,63
22352-19-8
D-MannoseS93057C6H12O6180.16
3458-28-4
L-MannoseS94058C6H12O6180.16
10030-80-5
Methyl 4,6-O-benzylidene-β-D-galactopyranosideS96060C14H18O6282,30 
6988-39-2
Methyl 4,6-O-benzylidene-α-D-glucopyranosideS97061C14H18O6282,30 
3162-96-7
Methyl 4,6-O-benzylidene-β-D-glucopyranosideS98062C14H18O6282,30
6988-39-2
Methyl 6-deoxy-α-L-mannopyranoside (Methyl a-L-rhamnopyranoside)S96063C7H14O5178,19
15814-59-2
Methyl α-D-fucopyranosideS96064C7H14O5178,19
1128-40-1
Methyl α-L-fucopyranosideS96065C7H14O5178,19
14687-15-1
Methyl β-D-galactopyranosideS96066C7H14O6194,18
1824-94-8
Methyl β-D-glucopyranoside hemihydrateS96067C7H14O6194,187000-27-3
Methyl β-D-ribopyranosideS97068C6H12O5164,16
17289-61-1
Methyl 2,3,5-tri-O-benzoyl-α-D-arabinofuranosideS98069C27H24O8476,49N/A
1,2,3,4,6-Penta-O-acetyl-β-D-galactopyranoseS95072C16H22O11390,35
4163-60-4
1,2,3,4,6-Penta-O-acetyl-α-D-mannopyranoseS99070C16H22O11390,35 
4163-65-9
D-Raffinose pentahydrateS96074C18H32O16 5H2O594,53
17629-30-0
L-Rhamnose monohydrateS94075C6H14O6182.17
10030-85-0
D-RiboseS93076C5H10O5150.13
50-69-1
L-RiboseS93077C5H10O5150.13 
24259-59-4
D-TagatoseS93079C6H12O6180.16
87-81-0
α-D-TaloseS93080C6H12O6180.16
2595-98-4
2,3,4,6-Tetra-O-acetyl-β-D-galactopyranosyl azideS96081C14H19N3O9373,32
13992-26-2
2,3,4,6-Tetra-O-acetyl-α-D-galactopyranosyl bromideS96082C14H19BrO9411.21
3068-32-4
2,3,4,6-Tetra-O-acetyl-β-D-glucopyranosyl azideS96083C14H19N3O9373,32
13992-25-1
2,3,4,6-Tetra-O-acetyl-α-D-glucopyranosyl bromideS94084C14H19BrO9411.21
572-09-8
1,3,4,6-Tetra-O-acetyl-β-D-mannopyranoseS97086C14H20O10348,3118968-05-3
2,3,4,6-Tetra-O-acetyl-α-D-mannopyranoseS97087C14H20O10348,31N/A
1,2,3,5-Tetra-O-acetyl-β-D-ribofuranoseS94088C13H18O9318.28
13035-61-5
2,3,4,6-Tetra-O-acetyl-1-thio-β-D-galactopyranoseS94089C14H20O9S364.37N/A
2,3,4,6-Tetra-O-acetyl-1-thio-β-D-glucopyranoseS94090C14H20O9S364.37
19879-84-6
2,3,4,6-Tetra-O-benzyl-α-D-galactopyranoseS96091C34H3606540.66
5308-25-7
2,3,4,6-Tetra-O-benzyl-α-D-glucopyranoseS93092C34H3606540.66
4132-28-9
2,3,4,6-Tetra-O-benzyl-α-D-mannopyranoseS96093C34H3606540.66
61330-61-8
1-Thio-β-D-galactose sodium saltS96094C6H11NaO5S218,21
42891-22-5
1-Thio-β-D-glucose sodium salt dihydrateS94095C6H11NaO5S x 2 H2O254.24
10593-29-0
3,4,6-Tri-O-acetyl-D-galactalS94097C12H16O7272.26
4098-06-0
D-Turanose (α-D-Glcp(1-3)-D-fructose)S93100C12H22O11342.30
547-25-1
D-XyloseS93101C5H10O5150.13
58-86-6
1,6-Anhydro-β-D-glucopyranose (Levoglucosan)S93015C6H10O5162,14
498-07-7
2-Azido-2-deoxy-1,3,4,6-tetra-O-acetyl-α-D-glucopyranoseS96023C14H19N3O9373,32N/A
<全国免费热线：400-6800-868
邮箱：sales@amyjet.com
客服QQ：2678079840
公司网址：www.amyjet.com



我们承诺：
（1）专业的服务：为您提供包括购买咨询、技术支持及实验方案制定在内的全方位服务；
（2）迅捷的货期：利用国际化的物流平台，大大缩短产品从厂家到最终用户的时间；
（3）过硬的品质：确保正品、质量和售后，多年客户积累，口碑保证。

公司简介：
艾美捷科技有限公司经营范围涵盖分子生物学试剂、免疫学试剂、细胞生物学试剂、蛋白质研究试剂、微生物学试剂、化学及生化试剂、材料学试剂、天然提取物、仪器设备等9大门类，累计约10万余种产品，充分满足不同客户的个性化需求；公司代理国外50余种一线品牌试剂，以“高性价比、迅捷的物流速度、专业的技术支持”，让客户充分享受全球化带来的便利；公司还增加了基因编辑、蛋白表达、细胞鉴定等定制项目，大大提升了为客户服务能力。“不忘初心，方得始终”，艾美捷科技将继续秉持“专心、专业、为您”的宗旨，以客户为根本，以诚信为基础，持续地为各界客户提供更加优质的产品和服务。

Glycon Biochemicals GmbH; Glycon Biochem; Glycon; S20031; S97085; S10191; S10192; S10189; S03293; S05174; S02174; D-20054; D-20055; D-20056; D97011; D20034; D99014; D07033; D97001; D97001-C; D99011; D99011-C; D99006; D11023; D99007; D99019-C; D99020; D20018; D14001; D20020; D20015; D20015-C; D99003; D99003-C; D99012; D99012-C; D97002-C; D20016; D20016-C; D20028-C; D20040-C; D20029-C; D97002; S02122; D99013; D20014; D14038-C; D20021; D20022-C; D99013-C; D20014-C; D98004; D99005; D99008; D20038; D20041; D20033; D20035; D20039; D20032; D20031; D20030; D71111; S98001; D20036; D99009; D99010; S10197; S10195; S10196; S10190; S10198; S10194; S10199; S01241; P0001; P0002; P0003; S96001; S93002; S98003; S94004; S94005; S96006; S97007; S00116; S96008; S96009; S96010; S98011; S98012; S11118; S98013; S99102; S93014; S97016; S93017; S96018; S96021; S97022; S96024; S96025; S97026; S97027; S97028; S97029; S96030; S96032; S94035; S97037; S95038; S00112; S95039; S93040; S00110; S96042; S96043; S95044; S93045; S94046; S97036; S00113; S02122-L; S02122-P; S94048; S00111; S96051; S96052; S98053; S98054; S93057; S94058; S96060; S97061; S98062; S96063; S96064; S96065; S96066; S96067; S97068; S98069; S95072; S99070; S96074; S94075; S93076; S93077; S93079; S93080; S96081; S96082; S96083; S94084; S97086; S97087; S94088; S94089; S94090; S96091; S93092; S96093; S96094; S94095; S94097; S93100; S93101; S93015; S96023; 10030-80-5; 10030-85-0; 10593-29-0; 106402-05-5; 106402-05-5; 111-03-5; 1114-34-7; 1128-40-1; 115457-83-5; 116183-64-3; 1172-03-8; 13035-61-5; 13343-62-9; 13343-63-0; 13992-25-1; 13992-26-2; 14131-84-1; 146801-07-2; 14687-15-1; 148565-58-6; 155548-45-5; 15814-59-2; 1643-20-5; 1707-77-3; 17289-61-1; 17629-30-0; 1811-31-0; 1824-94-8; 18449-82-6; 18549-40-1; 18615-50-4; 18968-05-3; 19046-60-7; 19327-39-0; 1949-78-6; 19879-84-6; 20031-21-4; 20881-04-3; 22352-19-8; 24259-59-4; 2438-80-4; 25339-99-5; 253678-64-7; 253678-65-8; 253678-67-0; 253678-67-0; 2595-98-4; 26183-52-81; 28697-53-2; 29557-51-5; 29781-80-4; 29836-26-8; 29836-26-8; 3055-98-9; 3055-99-0; 3068-32-4; 3068-34-6; 3162-96-7; 34384-797; 3458-28-4; 34819-86-8; 3615-37-0; 367-93-1; 367-93-1; 367-93-1; 369-84-4; 4026-27-1; 4064-06-6; 4098-06-0; 41308-76-3; 4132-28-9; 4163-60-4; 4163-65-9; 48149-72-0; 497-76-7; 498-07-7; 50444-86-5; 50-69-1; 5168-89-8; 5274-68-0; 528-50-7; 5308-25-7; 54400-75-8; 54400-77-0; 547-25-1; 572-09-8; 58066-85-6; 582-52-5; 58846-77-8; 58-86-6; 59080-45-4; 59122-55-3; 5996-14-5; 61330-61-8; 6167-32-4; 6205-69-2; 6363-53-7; 641-74-7; 644-76-8; 6540-99-4; 66-84-2; 69227-93-6; 69227-93-6; 6988-39-2; 6988-39-2; 69984-73-2; 69984-73-2; 7000-27-3; 70005-86-6; 70504-28-8; 71888-67-0; 7464-56-4; 7512-17-6; 75621-03-3; 7772-79-4; 7772-94-3; 77733-28-9; 78617-12-6; 82473-24-3; 82494-08-4; 82494-09-5; 82494-09-5; 85261-19-4; 85261-19-4; 85316-98-9; 85618-20-8; 85618-20-8; 85618-21-9; 85618-21-9; 85775-42-4; 870287-95-9; 87-81-0; 9043-30-5; 921-60-8; 93911-12-7; 93911-12-7; 98064-96-1; 98854-15-0; 98854-16-1

< " data-original="http://antibody.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理GLYCON Biochemicals全系列产品"> 艾美捷科技代理GLYCON Biochemicals全系列产品
...
阅读详情
logo .png

艾美捷科技代理DCN Dx品牌全系列产品

DCN Dx是一家专注于体外诊断(IVD)领域内快速即时诊断(POC)检测试剂的开发和制造的公司。快速免疫检测试剂的合约开发是DCN Dx所有业务的核心。Dcndx公司专注于侧向层析法（lateral flow）、穿流法（flow through）和微流控（microfluidic）技术平台，具有高灵敏度、定量检测、多重检测以及读数仪集成的高质量要求。DCNDx还提供多种产品和服务，以协助客户在开发的任何阶段：

● 定制的、私有的侧向层析技术教育培训课程： 在此课程中，将教授如何开发和制造快速检测试剂的细节；

● 咨询服务： 协助解决快速检测试剂开发、生产、法规注册和商业化过程中的任何问题；

● 定制化的蛋白-蛋白、蛋白-颗粒、小分子-蛋白和小分子-颗粒结合物；

● 侧向层析材料入门套件、结合物试剂盒、试剂、测试卡盒和材料： 用于快速检测试剂的开发过程。


▍DCN Dx产品列表

品名WeightDimensions产品描述
Blood Collection/Separation Materials Kit5.5 LBS10 × 14 × 3.5 IN集血液采集与红细胞分离功能于一体的套装设备
Nucleic Acid Lateral Flow Kit2 LBS14 × 12 × 4 IN兼容 DTT 的试剂盒检测标记的 DNA 扩增产物
Basic Lateral Flow Training--侧向层析技术能力提升
MICA-200C LFA Cassettes1.5 LBS12.25 × 11 × 1.5 IN高性能侧向层析 (LFA)卡盒
Lateral Flow Materials Kits16 LBS16 × 16 × 16 IN侧向层析材料套件
Colloidal Gold2.5 LBS8.5 × 3.5 × 3.5 INDCNovations胶体金，提供大宗采购优惠价
Cellulose NanoBeads--采用 NanoAct™纤维素纳米珠，增强侧向层析检测性能
CNB Conjugation Kit8 LBS16 × 16 × 16 IN为NanoAct™纤维素纳米珠提供可靠的偶联解决方案
Colloidal Gold Conjugation Kit9 LBS16 × 16 × 16 IN胶体金偶联试剂盒，优化蛋白-金标记物偶联物

" data-original="http://antibody.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理DCN Dx品牌全系列产品"> 艾美捷科技代理DCN Dx品牌全系列产品
...
阅读详情
Scripps LOGO 2.5比1.jpgexocell.jpg

艾美捷科技代理Scripps Laboratories 品牌。

Scripps Laboratories 是一家专注于生物化学试剂和免疫分析产品的公司，提供高质量的抗体、酶、蛋白质和免疫分析试剂盒，支持生命科学研究和临床诊断。Scripps Laboratories公司采用先进的生产和质控技术，确保产品的高质量和一致性；用于免疫学、细胞生物学和分子生物学研究；疾病诊断、生物标志物检测和健康监测；药物筛选、药效评估和毒性测试；生物制药、疫苗开发和生物材料研究。


Scripps Laboratories主要产品与服务包括：

（1）抗体：提供多种高特异性和高灵敏度的抗体，用于免疫学研究和诊断。

（2）酶和蛋白质：提供多种高纯度的酶和蛋白质，用于生物化学和分子生物学研究。

（3）免疫分析试剂盒：提供多种免疫分析试剂盒，包括 ELISA 试剂盒、蛋白质印迹试剂和细胞分析试剂。

（4）定制服务:根据客户需求，提供定制化的抗体和免疫分析试剂开发服务。




" data-original="http://antibody.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Scripps Laboratories品牌"> 艾美捷科技代理Scripps Laboratories品牌
...
阅读详情
669797ff94d9c.jpg

艾美捷科技代理SYnAbs品牌抗体。


SYnAbs公司针对免疫原性较差的化合物和复杂抗原进行开发，其抗体产品线范围包括：针对跨膜蛋白（GPCR、离子通道、转运蛋白）、类固醇、小分子、毒素、脂质和

多糖（针对真菌和细菌）的单克隆抗体。为了应对针对半抗原和膜蛋白产生创新单克隆抗体的挑战，SYnAbs公司开发了一整套技术，结合了：


（1）通过专有技术进行创新抗原设计SYnDNA载体、SYnCell同基因细胞系和特殊佐剂；

（2）专有大鼠LOU物种、野生型、敲除型和多种转基因物种（包括 ATX-Gx 转基因小鼠平台）的多物种免疫；

（3）独特的免疫策略打破免疫耐受并触发特定表位；

（4）稀有B细胞群的选择和分离。


部分单克隆抗体：

Rat anti-human CD2 Siplizumab (LO-CD2a/BTI-322)

Mouse anti-human chemokine receptor

Rat anti-Valproic acid hapten,Rat anti-galactomannan

IgG2b kappa rat anti-His tag (N-ter & C-ter)

IgG1 rat anti-human IgG4

IgG1 kappa rat anti-dinitrophenyl hapten


创新型一抗：

（1）高价值一抗针对复杂和小分子的一抗

（2）同型对照和不相关抗体（抗DNP）


大量二抗：SYnAbs公司为生物技术、制药和体外诊断公司提供大量二抗单克隆抗体目录（超过一百种二抗免疫球蛋白）。

< " data-original="http://antibody.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理SYnAbs品牌抗体"> 艾美捷科技代理SYnAbs品牌抗体
...
阅读详情
Norgen Biotek LOGO 2.5比1.jpg

艾美捷科技代理Norgen Biotek品牌。


Norgen Biotek由Yousef Haj-Ahmad博士于1998年创立。Norgen是一家获得ISO 9001、ISO 13485和ISO 15189认证的全面集成生物技术公司，为科学界提供全面的研究服务，如下

一代测序、核酸提取。


Norgen Biotek公司的产品范围包括：RNA、DNA、外切体和蛋白质提取的样品采集，保存，提取和检测相关产品。


（1）样本采集和保存：用于采集和保存各种样本（包括血液、血浆、尿液、粪便、唾液）的设备等等。

（2）纯化和分离：使用 Norgen 易于使用的试剂盒分离和纯化高质量的 RNA、DNA、蛋白质、外泌体等。

（3）NGS 文库制备试剂盒：简单快速的工作流程，用于准备您的下一个小型文库RNA-seq、RNA-seq 和宏基因组学。

（4）分子诊断：使用 Norgen 的 PCR 和 RT-PCR Taqman 检测试剂盒针对多种病原体。还提供其他引物和探针。

（5）实验室组件：酶、缓冲液、试剂、无核酸酶水、塑料和过滤设备。

< " data-original="http://antibody.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Norgen Biotek品牌"> 艾美捷科技代理Norgen Biotek品牌
...
阅读详情
Latest-Logo.png

<

艾美捷科技代理Biochemazone品牌全系列产品

Biochemazon是一家专注于生物技术领域的公司，可视为生化试剂和仪器的先驱者，致力于提供高质量和纯化的人工生物化学品、试剂和解决方案。提供模拟唾液、模拟尿液、模拟汗液等多种产品，满足学术研究单位、大学、医院、工业、政府和私人实验室等不同客户群体的需求。生化试剂经过全面测试，满足对品质的要求，能够以具有竞争力的价格准确模拟真实的生物溶液活性，满足生物制品的研发需求。Biochemazon的产品包括人工汗液、人工唾液、人工尿液、人工测试污垢、其他模拟体液、专用缓冲液与配方制剂、Biochemazone™ 采样拭子、运送培养基、即用型模拟体液粉剂以及脱水培养基。


Biochemazone页面.png


▍Biochemazone部分产品列表


NamePack Size
Artificial Canine Saliva or Simulated Canine Saliva (BZ297)100 mL,200mL,500mL,1000mL
Artificial Human Saliva BZ323100 mL,200mL,500mL,1000mL
Artificial Saliva AFNOR NF S91-141100 mL,200mL,500mL,1000mL
Artificial Saliva BZ319100 mL,200mL,500mL,1000mL
Artificial Saliva100 mL,200mL,500mL,1000mL
Artificial Saliva for Drug testing & Research100 mL,200mL,500mL,1000mL
Artificial Saliva for Food Products Testing (BZ463)100 mL,200mL,500mL,1000mL
Artificial Saliva100 mL,200mL,500mL,1000mL
Artificial Saliva BZ326100 mL,200mL,500mL,1000mL
Artificial Saliva for Pharmaceutical Research100 mL,200mL,500mL,1000mL
Artificial Saliva100 mL,200mL,500mL,1000mL
Artificial Saliva Mucin Added BZ389100 mL,200mL,500mL,1000mL
Artificial Saliva Mucin Added BZ390 as per ASTM E2720-16/ASTM E2721-16100 mL,200mL,500mL,1000mL
Artificial Saliva100 mL,200mL,500mL,1000mL
Artificial Saliva or Synthetic Saliva BZ324100 mL,200mL,500mL,1000mL
Artificial Saliva with a-Amylase Added BZ400100 mL,200mL,500mL,1000mL
Artificial Saliva with Cortisol (BZ411)100 mL,200mL,500mL,1000mL
Artificial Sublingual Saliva BZ432100 mL,200mL,500mL,1000mL
DIN 53160-1:2010-10 Artificial Saliva100 mL,200mL,500mL,1000mL
DIN 53160:2023-07 Compliant Saliva Simulant100 mL,200mL,500mL,1000mL
Fusayama/Meyer Artificial Saliva100 mL,200mL,500mL,1000mL
Human Oral Fluid Substitute " data-original="http://antibody.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Biochemazone品牌全系列产品"> 艾美捷科技代理Biochemazone品牌全系列产品
...
阅读详情
56575859606162636465